Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Ritonavir granted scientific approval from CPMP

May 31, 1996

Crixivan pediatric formulation in development

May 24, 1996

Adefovir dipivoxil to enter phase II/III in mid-1996

May 24, 1996

PRO-2000 begins phase I/II in Europe

May 24, 1996

Agouron presents Viracept trial results

May 24, 1996

PMPA: Candidate for clinical study in AIDS

May 24, 1996

Anti-HIV compounds isolated from marine organism

May 24, 1996

Excellent anti-HIV exhibited by RD4-2217

May 24, 1996

Oral anti-HIV oligosaccharide sulfate derivative presented at antiviral congress

May 24, 1996

Anti-HIV-1 activity demonstrated in mice by RKS-1443

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...